Bill > A08824

This bill enacts the "Manufacturer Disclosure and Transparency Act" in New York, which requires prescription drug manufacturers to notify the state Attorney General of any arrangements, agreements, or other actions that have the purpose or effect of delaying the introduction of generic versions of their brand-name drugs. The bill mandates that the Attorney General share this information with the state's Medicaid Utilization Review Board, Medicaid managed care plans, health carriers, and pharmacy benefit managers. It also requires the Attorney General to post all such notifications on a publicly accessible website, and imposes fines on manufacturers who fail to comply with the notification requirements.